BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

MIRM upcoming catalysts

Mirum Pharmaceuticals, Inc.: 1 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (0 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 3 readout(s) and 1 FDA event(s). Subscribe to MIRM (.ics).

Drugs: Volixibat

Upcoming FDA decision events

DateEventStatusCompanyDrugSource
No upcoming PDUFA date or AdCom found.

Upcoming trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2027-01 est.P2Mirum Pharmaceuticals, Inc. MIRMNCT05050136 A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary CholangitisPrimary Biliary Cholangitis; PBCactive not recruiting333

FDA decision events, last 12 months

DateEventStatusCompanyDrugSource
2026-09-25FDA approvalapprovedMIRUM MIRMATEBRIOZApproved 2026-09-25: ATEBRIOZ (NDA221198 ORIG1)

Trial readouts, last 12 months

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-08 est.P3Mirum Pharmaceuticals, Inc. MIRMNCT07298330 A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)Chronic Hepatitis D Infectionactive not recruiting80
2026-07-29P3Mirum Pharmaceuticals, Inc. MIRMNCT06553768 Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)active not recruiting90
2026-02-20P2Mirum Pharmaceuticals, Inc. MIRMNCT04663308 A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)Primary Sclerosing Cholangitisactive not recruiting182

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.